You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 抗疫概念股走強 變異毒株奧密克戎引擔憂
格隆匯11月29日丨康希諾生物漲9%,君實生物漲近7%,開拓藥業漲5%,復星醫藥,騰盛博藥,阿里健康,中國生物製藥漲3%,京東健康漲2%。消息面上,世衞組織11月26日發佈聲明,將B.1.1.529新冠變異毒株列為“需要關注“的變異株,並命名為奧密克戎(Omicron)。世界衞生組織在11月28日指出,新冠變異病毒奧密克戎毒株有幾處突變可能對其傳播能力和致病程度產生影響,但目前尚不清楚奧密克戎毒株是否比其他變異株更具傳染性,以及是否會導致更嚴重的疾病。此前,世衞組織已表示,奧密克戎毒株導致再感染的風險可能增加,但信息有限,世衞組織正與合作伙伴進行研究,以瞭解奧密克戎毒株對現有新冠疫苗有效性和檢測工具的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account